Effect of Timing of Oocyte Denudation Before ICSI in an Oocyte Donation Model

November 27, 2020 updated by: Hospital Italiano de Buenos Aires

Effect of Timing of Oocyte Denudation Before ICSI and Its Results in an Oocyte Donation Model: a Cluster Randomized Controlled Clinical Trial

Analyze the effect of preincubation time of oocyte on the results of ICSI in a oocyte donation model.

Study Overview

Detailed Description

There is an intense communication inside the follicular structure. Bidirectional information between the oocyte and the granulosa cells is needed for a normal follicular development and oocyte competence.

There are conflicting results on the effect of pre-incubation time in ICSI.

It is not clear the proper time to denudate the oocyte from the somatic cells prior to ICSI, and some authors describe a negative impact of the premature cummulus removal on the ICSI results.

The aim of this study is to investigate wheter a preincubation time between oocyte retireval and injection has any effect on the ICSI ( intracytoplasmatic sperm injection) results .

Study Type

Interventional

Enrollment (Actual)

375

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Buenos Aires
      • Ciudad de buenos Aires, Buenos Aires, Argentina, C1199ABB
        • Hospital Italiano de Buenos Aires

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 32 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Oocytes retrieved from healthy donors, younger than 32 years old , with proven maternity(preference), who meet the admission criteria of ovodonation program:
  • The oocytes included will be the product of antagonist stimulation protocol and with Gnrh agonists trigger. (see annex)
  • Healthy women under 50 years of age , who meet the criteria as receptors into the ovodonation program.
  • Oocytes retrieved after 36.5 h + -1 h of administration of triptorelin acetate.
  • Only mature oocytes, in stage MII, will be included and injected.
  • Use of fresh or thawed semen for the ICSI.

Exclusion Criteria:

  • Cases of severe male factor such as azoospermia or severe oligo-astheno-teratospermia( alone or combinated)
  • Sperm samples from surgical procedures (biopsy / testicular or epididymal puncture)
  • Donors with a polycystic ovarian profile, according to The Androgen Excess and PCOS Society (AES), 2006.
  • Thawed donated oocytes
  • Oocytes from patients who have previously donated within a period of less than three months.
  • Donors whith poor response (oocyte retrieved less than < 4 oocytes).
  • Suspicion or signs of Endometriosis in donor patient.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immediately oocyte denudation

After the retrieval , sybling oocytes were assigned to one o more recipient and then ,the oocytes were randomized in two arms .

The first arm is the immediately denudation and immediately ICSI of the oocytes, and in the second arm the oocyte are denuded and injected after 4 hours from the pick up .

Donated oocytes were randomly allocated to two groups concerning the time of cumulus corona removal.

The first group: After oocyte retrieval, cumulus cells were immediately removed and then ICSI was performed; in the second group, the oocyte-cumulus complexes were incubated for 4 hours. Afterwards, the granulosa cells were removedand ICSI was immediately performed.

Other Names:
  • cumulus corona removed
  • granulosa cells removed
Experimental: Delayed oocyte denudation

After the retrieval , sybling oocytes were assigned to one o more recipient and then ,the oocytes were randomized in two arms .

In this arm, the oocyte are denuded and injected after 4 hours from the pick up .

Donated oocytes were randomly allocated to two groups concerning the time of cumulus corona removal.

The first group: After oocyte retrieval, cumulus cells were immediately removed and then ICSI was performed; in the second group, the oocyte-cumulus complexes were incubated for 4 hours. Afterwards, the granulosa cells were removedand ICSI was immediately performed.

Other Names:
  • cumulus corona removed
  • granulosa cells removed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of M2 oocytes at injection
Time Frame: four hours after oocyte retrieval
Asessment of the number of M2 oocytes was made after the oocyte denudation and ICSI
four hours after oocyte retrieval
Number of normal fertilized oocytes after ICSI
Time Frame: 24 hours
Asessment of the normal fertilization rate was made 24 hours after the intervention.
24 hours
Number of cleaving embryos
Time Frame: 72 hours
The embryo cleavage was evaluated after 48 hours and 72 hours after the ICSI was performed.
72 hours
Number of TOP embryos
Time Frame: 72 hours
The embryos were morfologically classified into 4 categories . It considered TOP embryos those correctly fertilized at day 1, and with regular 6 to 8 cells at day 2 with less than 20% fragmentation and without multinuclear blastomeres.
72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implantation rate
Time Frame: 14 days after embryo trasfer
The implantation rate was the ratio between the number of gestacional sacs and the number of transferred embryos.
14 days after embryo trasfer
Clinical pregnancy rate
Time Frame: 6 to 7 week
Clinical pregnancy is confirmed by ultrasonography ,when one or more gestational sacs with heart activity are seen.
6 to 7 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Romina I Pesce, MD, Hospital Italiano de Buenos Aires

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

August 1, 2019

Study Registration Dates

First Submitted

September 27, 2016

First Submitted That Met QC Criteria

April 17, 2017

First Posted (Actual)

April 20, 2017

Study Record Updates

Last Update Posted (Actual)

December 1, 2020

Last Update Submitted That Met QC Criteria

November 27, 2020

Last Verified

August 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2500

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fertility

Clinical Trials on timing for oocyte denudation and Intracytoplasmatic Sperm injection

Subscribe